MarketBeat Daily Ratings for Monday, September 30, 2024
Ratings changes for Vanda Pharmaceuticals, Key Tronic, Xunlei, Frontier Group, Veradigm, Prothena, Meta Platforms and more...Text "MarketBeat" to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.September 30th, 2024 | My grim warning about AI stocks (ad)Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming. So go here now to read my new report The Big AI Die-Up… while you still can. |
|
Today's Top Stories | | By Jea Yu | September 30, 2024 09:40 AM |
| | | By The Associated Press | September 30, 2024 09:22 AM |
| | By Gabriel Osorio-Mazilli | September 30, 2024 09:03 AM |
| | | By The Associated Press | September 30, 2024 09:01 AM |
| | By Chris Markoch | September 30, 2024 08:46 AM |
|
|
Analysts' Upgrades | Accenture (NYSE:ACN) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating. They now have a $400.00 price target on the stock, up previously from $321.00. This represents a 13.5% upside from the current price of $352.38. | Amerant Bancorp (NASDAQ:AMTB) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $26.50 price target on the stock, up previously from $26.00. This represents a 24.4% upside from the current price of $21.30. | Brookfield Renewable Partners (NYSE:BEP) (TSE:BEP) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $31.00 price target on the stock, up previously from $24.00. This represents a 9.2% upside from the current price of $28.40. | Brown-Forman (NYSE:BF.B) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $53.00 price target on the stock, up previously from $43.00. This represents a 7.8% upside from the current price of $49.17. | Brown-Forman (NYSE:BF-B) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $53.00 price target on the stock, up previously from $43.00. This represents a 9.6% upside from the current price of $48.34. | BlackLine (NASDAQ:BL) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $70.00 price target on the stock, up previously from $60.00. This represents a 27.1% upside from the current price of $55.09. | Cadence Bank (NYSE:CADE) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $39.00 price target on the stock, up previously from $36.00. This represents a 22.3% upside from the current price of $31.89. | Hess (NYSE:HES) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $150.00 price target on the stock. This represents a 10.8% upside from the current price of $135.41. | Inotiv (NASDAQ:NOTV) was upgraded by analysts at Lake Street Capital from a "hold" rating to a "buy" rating. They now have a $4.00 price target on the stock, up previously from $2.00. This represents a 128.9% upside from the current price of $1.75. | Frontier Group (NASDAQ:ULCC) was upgraded by analysts at Raymond James from an "underperform" rating to a "market perform" rating.The current price is $5.24. | U.S. Bancorp (NYSE:USB) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $57.00 price target on the stock, up previously from $54.00. This represents a 25.7% upside from the current price of $45.33. | Westlake (NYSE:WLK) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $180.00 price target on the stock, up previously from $162.00. This represents a 20.5% upside from the current price of $149.36. | Zions Bancorporation, National Association (NASDAQ:ZION) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $54.00 price target on the stock. This represents a 14.6% upside from the current price of $47.13. |
| View More Upgrades
|
Analysts' Downgrades | Bruker (NASDAQ:BRKR) was downgraded by analysts at Wolfe Research from an "outperform" rating to a "peer perform" rating.The current price is $69.56. | Commerce Bancshares (NASDAQ:CBSH) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $64.00 price target on the stock, down previously from $66.00. This represents a 6.9% upside from the current price of $59.85. | Charter Communications (NASDAQ:CHTR) was downgraded by analysts at Wolfe Research from a "peer perform" rating to an "underperform" rating. They now have a $300.00 price target on the stock. This represents a 7.9% downside from the current price of $325.87. | Enbridge (NYSE:ENB) (TSE:ENB) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating.The current price is $40.49. | EnLink Midstream (NYSE:ENLC) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $16.00 price target on the stock. This represents a 10.1% upside from the current price of $14.53. | Freeport-McMoRan (NYSE:FCX) was downgraded by analysts at Scotiabank from a "sector outperform" rating to a "sector perform" rating. They now have a $52.00 price target on the stock. This represents a 3.2% upside from the current price of $50.38. | Frontier Communications Parent (NASDAQ:FYBR) was downgraded by analysts at Wolfe Research from an "outperform" rating to a "peer perform" rating.The current price is $35.41. | Interpublic Group of Companies (NYSE:IPG) was downgraded by analysts at BNP Paribas from a "neutral" rating to an "underperform" rating.The current price is $31.64. | JPMorgan Chase & Co. (NYSE:JPM) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $224.00 price target on the stock, up previously from $220.00. This represents a 6.8% upside from the current price of $209.65. | Procter & Gamble (NYSE:PG) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating. They now have a $163.00 price target on the stock. This represents a 6.2% downside from the current price of $173.79. |
| View More Downgrades
|
Analysts' New Coverage | Adicet Bio (NASDAQ:ACET) is now covered by analysts at Guggenheim. They set a "buy" rating and a $7.00 price target on the stock. This represents a 368.2% upside from the current price of $1.50. | BioLife Solutions (NASDAQ:BLFS) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $29.00 price target on the stock. This represents a 15.4% upside from the current price of $25.14. | Crescent Capital BDC (NASDAQ:CCAP) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating and a $20.00 price target on the stock. This represents a 8.3% upside from the current price of $18.46. | Celldex Therapeutics (NASDAQ:CLDX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $45.00 price target on the stock. This represents a 35.6% upside from the current price of $33.19. | Horizon Bancorp (NASDAQ:HBNC) is now covered by analysts at Hovde Group. They set an "outperform" rating and a $18.00 price target on the stock. This represents a 16.8% upside from the current price of $15.41. | Klaviyo (NYSE:KVYO) is now covered by analysts at Benchmark Co.. They set a "buy" rating and a $42.00 price target on the stock. This represents a 17.0% upside from the current price of $35.90. | Navient (NASDAQ:NAVI) is now covered by analysts at Bank of America Co.. They set a "neutral" rating and a $17.00 price target on the stock. This represents a 8.8% upside from the current price of $15.62. | OSI Systems (NASDAQ:OSIS) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $175.00 price target on the stock. This represents a 18.2% upside from the current price of $148.10. | Permian Resources (NYSE:PR) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $19.00 price target on the stock. This represents a 39.5% upside from the current price of $13.62. | ProKidney (NASDAQ:PROK) is now covered by analysts at JPMorgan Chase & Co.. They set a "neutral" rating on the stock.The current price is $1.91. | Skye Bioscience (NASDAQ:SKYE) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $20.00 price target on the stock. This represents a 411.5% upside from the current price of $3.91. | SelectQuote (NYSE:SLQT) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $4.50 price target on the stock. This represents a 101.3% upside from the current price of $2.24. | Tenax Therapeutics (NASDAQ:TENX) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $3.50. | Verastem (NASDAQ:VSTM) is now covered by analysts at Guggenheim. They set a "buy" rating and a $13.00 price target on the stock. This represents a 356.1% upside from the current price of $2.85. |
| View More New Coverage
|
Calendars from MarketBeat | |
|
Get 30 Days of MarketBeat All Access Free | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. | Start Your 30-Day Free Trial |
| Upgrade Your Subscription | Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. | Upgrade Now |
|
| Manage Your Watchlist | View and add up to five holdings to your watchlist. | View My Portfolio |
|
| Join Our Facebook Group | Join MarketBeat’s free stock discussion and trading idea group on Facebook. | Join Now |
| Thank you for subscribing to MarketBeat!We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com. If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails. © 2006-2024 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States. Today's Bonus Content: Warren Buffett Is Sitting on $278 Billion in Cash—Should You Be Worried? |